The Hong Kong Center for Clinical Research is the first and the largest clinical trials center in the private sector in Hong Kong. It was established in 2007. More than 30 projects have been completed in collaboration with leading biotechnology and pharmaceutical companies. FDA and EMA audits generated excellent compliance reports.
Our uniqueness are: large patient database, tested recruitment methods, patient retention models, regular GCP training, robust quality assurance and standard operating procedures.
The areas of research include musculoskeletal diseases, ophthalmology, rheumatology , oncology, women’s health and other areas.
To collaborate with biotechnology, pharmaceutical, devices and diagnostic companies to design and conduct clinical trials, so that new drugs, devices and diagnostic tests can be brought to the market in the most cost-effective manner.
To contribute substantial ethnic Chinese patient data to clinical trials, so that new drugs, devices and diagnostic tests can be rapidly registered with the NMPA of China, as well as the FDA and EMA.